Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

164.90
BATS BZX Real-Time Price
As of 11:58am ET
 +4.67 / +2.91%
Today’s Change
89.76
Today|||52-Week Range
217.99
+10.41%
Year-to-Date
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Allergan Buys NASH Therapy Maker Tobira at Huge Premium
Sep 21 / Zacks.com - Paid Partner Content
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sep 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close160.23
Today’s open161.00
Day’s range159.38 - 164.90
Volume7,570
Average volume (3 months)490,720
Market cap$4.0B
Dividend yield--
Data as of 11:58am ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-69.26%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book6.49

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.49-1.50%
GRFSGrifols SA+0.19+1.20%
AGNPRAAllergan plc-1.56-0.19%
PTHNPatheon NV-0.05-0.17%
Data as of 12:01pm ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$3.83
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer
Sandip Kapadia
Corporate headquarters
New York, New York

Forecasts

Search for Jobs